spacer
home > pmps > winter 2001 > digital printing for pharmaceutical packaging - a customer's perspective
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Digital Printing for Pharmaceutical Packaging - A Customer's Perspective

As digital printing becomes a more viable option for packaging, printing vendors are looking to the pharmaceutical industry as a lucrative market. There are several reasons why digital printing is suitable for pharmaceutical packaging:

The option of quick turnaround for printed materials is
especially attractive in an industry which is under increasing
pressure to bring products to launch

Frequent changes to packaging make any options which
reduce the inventory of printed materials very advantageous

Rapid safety changes are often necessary for
pharmaceutical products

While the cost of printed materials is not a major portion
of the cost of the product for large orders of pharmaceutical
products, this is not always true for short run, small volume
products.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Susan B. McNeely, Associate Engineering Consultant at Eli Lilly and Company in the US
Susan McNeely is a member of Eli Lilly and Company's corporate team, which provides technical support to Lilly packaging sites worldwide.
She is a Chemist by training and her previous assignments at Lilly include printed packaging development, pharmaceutical product development and quality assurance. Prior to joining Lilly, Susan worked at RCA and the University of Cincinnati Medical Center.

spacer
Susan B. McNeely
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Sartorius Stedim Biotech Launches New Services for Mammalian Cell Bank Manufacturing

GOETTINGEN, Germany and GLASGOW, UK, August 08, 2019 / B3C newswire / -- Sartorius Stedim Biotech (SSB), a leading partner of the biopharmaceutical industry, today announced the launch of new services for mammalian cell bank manufacture under GMP conditions. These services are offered by its subsidiary, Sartorius Stedim BioOutsource, an experienced contract testing organization (CTO) based in Glasgow, UK, and in Cambridge, Massachusetts, USA.
More info >>

White Papers

Mouse Models for Evaluation of Vaccines and Therapeutics Against Staphylococcal Infections

IBT Bioservices

Introduction Staphylococcus aureus (SA) is a ubiquitous, formidable Gram-positive pathogen associated with skin and soft tissue, as well as lifethreatening systemic infections. SA is a leading cause of hospital- and community-associated infections worldwide, affecting humans and animals. The wide range of pathologies reflects the diverse abilities of this microbe to escape the innate and adaptive immune response using virulence factors. Since its first emergence in the 1960s methicillin-resistant SA (MRSA) has become endemic in hospitals and healthcare settings worldwide. In the 1990s, community associated MRSA strains (CA-MRSA) emerged, and are spreading worldwide posing a major global challenge.
More info >>

 
Industry Events

PPMA Total Show

1-3 October 2019, Birmingham

About PPMA Total Show PPMA Total is one of UKs largest processing and packaging machinery exhibitions. Building on the success of the PPMA Show in 2018, PPMA Total returns to the NEC, Birmingham, on 1-3 October 2019 for another show-stopping event.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement